|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Cystic fibrosis (CF) airway epithelia are characterized by enhanced Na+ absorption probably due to a lack of downregulation of epithelial Na+ channels by mutant CF transmembrane
conductance regulator. Extracellular nucleotides adenosine 5'-triphosphate (ATP) and uridine 5'-triphosphate (UTP) have
been shown to activate alternative Ca2+-dependent Cl
channels in normal and CF respiratory epithelia. Recent studies suggest additional modulation of Na+ absorption by extracellular nucleotides. In this study we examined the role of mucosal ATP and UTP in regulating Na+ transport in native human upper airway tissues from patients with 16 patients with
CF and 32 non-CF control subjects. To that end, transepithelial voltage and equivalent short-circuit current (ISC) were
assessed by means of a perfused micro-Ussing chamber. Mucosal ATP and UTP caused an initial increase in lumen-negative ISC that was followed by a sustained decrease of Isc in
both non-CF and CF tissues. The amiloride-sensitive portion of
ISC was inhibited significantly in normal and CF tissues in the
presence of either ATP or UTP. Both basal Na+ transport and
nucleotide-dependent inhibition of amiloride-sensitive ISC
were significantly enhanced in CF airways compared with
non-CF. Nucleotide-mediated inhibition of Na+ absorption
was attenuated by pretreatment with the Ca2+-adenosine
triphosphatase inhibitor cyclopiazonic acid but not by inhibition of protein kinase C with bisindolylmaleimide. These data
demonstrate sustained inhibition of Na+ transport in non-CF
and CF airways by mucosal ATP and UTP and suggest that this
effect is mediated by an increase of intracellular Ca2+. Because
ATP and UTP inhibit Na+ absorption and stimulate Cl
secretion simultaneously, extracellular nucleotides could have a
dual therapeutic effect, counteracting the ion transport defect in CF lung disease.
| |
Introduction |
|---|
|
|
|---|
Two prevailing alterations of ion transport have been well
characterized in cystic fibrosis (CF) lung disease: a defect
in cyclic adenosine monophosphate-dependent Cl
secretion, and enhanced amiloride-sensitive Na+ absorption (1-
3). There is a large body of evidence that the epithelial
Na+ channel (ENaC) is downregulated by the CF transmembrane conductance regulator (CFTR) (4, 5). Thus, increased
ENaC activity in CF respiratory and colonic tissues is caused
by a lack of regulation of ENaC by mutant CFTR (6),
causing hyperabsorption of electrolytes, thereby leading to
increased mucous viscosity and reduced mucociliary clearance in the airways of patients with CF. Therapeutic strategies aim at restoring defective Cl
secretion and reducing
enhanced Na+ absorption. The 5'-nucleotides adenosine
5'-triphosphate (ATP) and uridine 5'-triphosphate (UTP)
have been shown to activate alternative Ca2+-dependent
Cl
channels in murine and human normal and CF respiratory epithelia (10). The pharmacologic profile observed
in these studies suggests that ATP and UTP act via binding to the P2Y2 receptor expressed on the luminal membrane of polarized respiratory epithelial cells (15). This
was confirmed recently in studies on P2Y2 receptor (
/
)
mice in which ATP- and UTP-mediated Ca2+ signaling and
Cl
secretory responses were largely abolished (18, 19).
These results triggered clinical trials in which both UTP
and amiloride were applied simultaneously to counteract
the ion transport defect in CF (20).
CFTR plays an important role in regulating ENaC in
airway and intestinal epithelia (6). In kidney epithelia,
Na+ absorption is modulated by changes in intracellular
Ca2+, and Ca2+-mediated agonists have been demonstrated
to inhibit ENaC located in the apical membrane of the cortical collecting duct (21). Similar results were obtained
in airways of different species and cultured human bronchial epithelial cells expressing wild-type or
F508 CFTR.
In these tissues, inhibition of Na+ absorption was elicited
by extracellular nucleotides and other Ca2+-mediated agonists (24). Because no data are available from the original human tissue, we examined the effects of extracellular purine and pyrimidine triphosphates on epithelial Na+ absorption in native human upper airway epithelium. For this purpose nasal tissues were mounted in a perfused micro-Ussing chamber and the effects of ATP and UTP on transepithelial voltage (Vte) and equivalent short-circuit current (ISC) were determined. The effects of ATP and UTP on
native normal and CF upper airways were compared.
| |
Materials and Methods |
|---|
|
|
|---|
Ussing Chamber Experiments
Freshly excised nasal tissues were obtained from 32 non-CF individuals (mean age: 37.0 ± 2.8 yr, range 5 to 72 yr; 20 males, 12 females) after surgery for plastic reconstruction or sleep apnea syndrome and from 16 CF patients (13 ± 2.4 yr, range 4 to 38 yr; 7 males, 9 females) after polypectomy. The study was approved by
the Ethical Committee at the University Hospital, Albert-Ludwigs-University Freiburg. Nasal tissues were kept in ice-cold
buffer solution of the following composition (mmol/liter): NaCl
127, KCl 5, D-glucose 5, MgCl2 1, Na-pyruvate 5, N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid 10, CaCl2 1.25, and albumin
(10 g/liter). A thin layer of nasal epithelium was dissected from
the stroma and mounted into a perfused micro-Ussing chamber
with a circular aperture of 0.95 mm2 as described previously (13).
In brief, the luminal and basolateral sides of the epithelium were
perfused continuously at a rate of 10 ml/min (chamber volume 1 ml).
The bath solution had the following composition (mmol/liter):
NaCl 145, KH2PO4 0.4, K2HPO4 1.6, D-glucose 5, MgCl2 1, and
Ca-gluconate 1.3. The pH was adjusted to 7.4. Bath solutions
were heated by a water jacket and all experiments were carried
out at 37°C. Experiments were performed under open-circuit conditions. Transepithelial resistance (Rte) was determined by applying short (1 s) current pulses (
I = 0.5 µA) and the corresponding changes in Vte (
Vte) and basal Vte were recorded continuously. Values for Vte were referred to the serosal side of the epithelium. Rte was calculated according to Ohm's law. The Isc was determined from Vte and Rte, i.e., ISC = Vte/Rte.
Experimental Protocols
After mounting the tissues in the Ussing chamber, an equilibration period of 60 min was allowed for stabilization of basal Vte and Rte. Continuous perfusion of the luminal and basolateral sides of the epithelium allowed us to study ATP- and UTP-mediated inhibition of Na+ absorption in a strictly paired fashion. First, the effect of amiloride (10 µmol/liter, luminal solution) was determined under control conditions. The effect of amiloride was entirely reversible on washout for 30 min. Next the effect of mucosal ATP (100 µmol/liter, luminal solution) or UTP (100 µmol/liter, luminal solution) was examined. Both ATP and UTP typically induced a biphasic response with a transient initial increase in ISC (peak) followed by prolonged inhibition (plateau). In the plateau phase, amiloride was added in the presence of ATP or UTP. Inhibition of Na+ absorption was determined by comparing the amiloride-sensitive ISC in the absence and presence of ATP or UTP. Inhibition of Na+ transport by extracellular nucleotides was reversible upon 60 min washout. To examine the role of intracellular Ca2+ and protein kinase (PK) C as possible second messengers involved in nucleotide-mediated inhibition of amiloride-sensitive ISC, tissues were incubated for 20 min with either the Ca2+-adenosine triphosphatase (ATPase) inhibitor cyclopiazonic acid (CPA) (50 µmol/ lliter) or the PKC inhibitor bisindolylmaleimide (BIM) (200 nmol/ liter) added on both sides of the epithelium.
Compounds and Data Analysis
Amiloride, ATP, UTP, CPA, and BIM I were all obtained from
Sigma (Deisenhofen, Germany). All used chemicals were of
highest grade of purity available. Data are shown as individual recordings or as means ± standard error of the mean (n = number
of tissue samples). The fractional (%) inhibition of Na+ transport
was determined from the amiloride-sensitive ISC under control
conditions (
IAmil-Con) and the amiloride-sensitive ISC in the presence of ATP or UTP (
IAmil-ATP/UTP) as follows: inhibition (%) = 1
(
IAmil-ATP/UTP)/(
IAmil-Con). Statistical analysis was performed using paired Student's t test. Data obtained from CF and
non-CF tissues were compared by unpaired Student's t test. P values < 0.05 were accepted to indicate statistical significance.
| |
Results |
|---|
|
|
|---|
Effect of Luminal ATP on Na+ Transport in Normal and CF Nasal Epithelia
The effect of extracellular ATP on Na+ absorption in native human nasal tissues was studied after mounting small
epithelial sheaths in a perfused micro-Ussing chamber.
Amiloride-sensitive ISC was measured in the absence and
presence of ATP (100 µmol/liter), applied to the mucosal
side of the epithelium. Basal bioelectric properties were
determined after a 60-min equilibration period in the
Ussing chamber. In non-CF tissues lumen-negative ISC was
61.0 ± 6.4 µA/cm2 (Vte =
1.2 ± 0.1 mV; Rte = 22.1 ± 2.4
cm2; n = 21). In CF tissues (n = 12), basal ISC and Vte
were significantly increased (
245.6 ± 42.9 µA/cm2 and
3.8 ± 0.8 mV) and Rte was reduced (15.2 ± 1.6
cm2)
compared with non-CF (Figures 1 and 2A). The contribution of electrogenic Na+ absorption to transepithelial transport was determined by adding amiloride (10 µmol/liter)
to the luminal side of the epithelium. As expected from
previous studies (8, 28) the amiloride-sensitive ISC was significantly increased in CF (
ISC = 222.1 ± 37.7 µA/cm2, n = 12) compared with non-CF (
ISC = 45.7 ± 4.8 µA/cm2, n = 21) (Figures 1 and 2B). The effect of amiloride was entirely reversible on washout for 30 min. Next, the effect of
mucosal ATP (100 µmol/liter) was examined. In non-CF
tissues, perfusion with luminal ATP caused a transient increase of lumen-negative ISC that was followed by sustained inhibition. When amiloride was added in the presence of ATP the amiloride-sensitive ISC was significantly
reduced by 50.3 ± 3.9% (n = 21; Figures 1A and 2). In CF
tissues, mucosal ATP induced a similar ISC response with an initial transient increase followed by prolonged inhibition of lumen-negative ISC. Addition of amiloride in the
presence of ATP revealed a reduction of amiloride-sensitive ISC by 54.8 ± 4.3% (n = 12; Figures 1B and 2). Thus,
the fractional (%) inhibition of amiloride-sensitive ISC by
extracellular ATP was similar in normal and CF tissues.
However, the absolute magnitude of amiloride-sensitive ISC inhibited by ATP was significantly increased in CF
compared with that in non-CF tissues (CF:
IscAmil =
119.2 ± 22.8 µA/cm2, n = 12 versus non-CF:
IscAmil =
22.6 ± 3.1 µA/cm2, n = 21). The data demonstrate that
Na+ absorption is significantly reduced by application of
luminal ATP in normal and CF nasal tissue and that a
larger amount of ISCAmil is inhibited in CF airways.
|
|
Effect of Luminal UTP on Na+ Transport in Normal and CF Nasal Epithelia
Different subtypes of nucleotide receptors have been described on the luminal surface of epithelia with a different
rank order of potency for ATP, UTP, and their diphosphate
nucleotides and analogues. P2Y2 receptors expressed on
murine and human airway epithelial cells are similarly activated by ATP or UTP but not by diphosphate nucleotides
(15, 19). To determine whether nucleotide-induced inhibition of Na+ absorption was mediated by P2Y2 receptors, we further examined the effect of UTP (100 µmol/liter) on amiloride-sensitive ISC. In both non-CF and CF
tissues, UTP-induced changes of ISC were comparable with
the observations made for ATP. Addition of UTP resulted
in a lumen-negative peak response that was followed by marked and sustained inhibition of transepithelial ISC (Figures 3 and 4). A detailed analysis of the time course of the
UTP response was obtained from five CF tissues (Figure
5); the figure shows that the transient lumen-negative UTP
response returned to baseline within 2 min. Maximal UTP-induced inhibition of ISC was observed after approximately
7 min. Compared with the transient initial increase, inhibition of ISC was sustained in the presence of UTP and gradually reversible on washout (Figure 5). A similar time course
was obtained in non-CF tissues. In the presence of UTP, the amiloride-sensitive ISC was significantly inhibited in
non-CF (by 39.5 ± 6.1%, n = 15) and CF tissues (by 45.4 ± 2.6%, n = 15), respectively. As observed for ATP, the absolute inhibitory effect of UTP on amiloride-sensitive ISC
was significantly increased in CF (
ISCAmil =
73.8 ± 12.7 µA/cm2, n = 15) compared with non-CF tissues (
ISCAmil =
19.7 ± 3.9 µA/cm2, n = 15) (Figures 3 and 4B).
|
|
|
Signal Transduction Pathways in UTP-Mediated Inhibition of Na+ Absorption
Amiloride-sensitive Na+ conductance in non-CF and CF upper airway tissues was equally inhibited by ATP and UTP, suggesting that the response was mediated by the P2Y2 receptor. P2Y2 receptor activation has been shown to be coupled to phospholipase (PL) C, resulting in an increase in inositol trisphosphate and diacylglycerol (16, 29). Therefore, the inhibitory effects of ATP and UTP could be mediated by either increase of intracellular Ca2+ or activation of PKC. We examined the potential role of intracellular Ca2+ in inhibition of Na+ absorption in CF tissues by adding the Ca2+-ATPase inhibitor CPA (50 µmol/liter). Basal ISC and amiloride-sensitive ISC were significantly inhibited by CPA (Figure 6B). After a 20-min incubation period with CPA, both the initial lumen-negative UTP peak response and the prolonged UTP plateau response were significantly reduced in CF nasal tissues (Figures 6A and 6C). These results indicate that UTP-dependent inhibition of Na+ absorption is mediated by an increase of intracellular Ca2+. To investigate a possible role of PKC activation in nucleotide-mediated inhibition of amiloride-sensitive ISC, CF tissues were incubated with the PKC inhibitor BIM (200 nmol/liter). As shown in Figure 7, PKC inhibition had no effect on basal ISC, amiloride-sensitive ISC, or UTP-dependent inhibition of Na+ absorption (Figure 7). These data suggest that intracellular Ca2+ signaling, but not PKC, is involved in nucleotide-mediated inhibition of Na+ transport.
|
|
| |
Discussion |
|---|
|
|
|---|
CF airways demonstrate enhanced Na+ absorption, which
is caused by a lack of ENaC downregulation when CFTR
is defective (4). Apart from CFTR, binding of nucleotides such as ATP or UTP to luminal P2Y2 receptors has
recently been shown to modulate Na+ absorption in various epithelia. Inhibition of Na+ transport by extracellular
nucleotides has been reported for rabbit trachea, rat distal
airway cells, porcine bronchi, and cultured human bronchial epithelial cells (24). This effect exists in addition
to the well-described activation of Ca2+-dependent Cl
channels, apparently expressed in the luminal membrane
of normal and CF airways (10, 11, 14, 17, 19, 29). These
previous reports prompted us to examine whether (1) nucleotide-dependent inhibition of Na+ absorption takes
place in native human airways; (2) inhibition of Na+ transport is different in CF compared with normal airways; and (3) Ca2+-dependent intracellular signaling participates in
inhibition of Na+ absorption. Due to limited accessibility
of lower airway tissue from normal and CF individuals we
used freshly excised nasal epithelium, which has been
shown to have similar ion conduction properties compared
with lower airways and has been well characterized for the
ion transport defects in CF (2, 28).
Regulation of Na+ transport in human proximal airways was studied by assessing the effects of ATP and UTP
on amiloride-sensitive ISC in epithelial sheaths mounted in
a modified perfused micro-Ussing chamber. As reported
previously (8), the exposed tissue area was reduced to 0.95 mm2 to be able to examine very small samples of native
human epithelium. Due to edge leak conductance, the measured Vte and Rte values were certainly underestimated
compared with in vivo studies (11) or previous measurements on human nasal tissues using Ussing chambers with
a larger-size open area (28). However, bioelectric properties of our preparations corresponded well to measurements of upper murine airways mounted in small-size
Ussing chambers (7). Despite imperfect edge-sealing, typical CF alterations of ion transport (e.g., enhanced Na+ absorption) were well preserved; Vte and Rte were stable during the whole course of the experiments; and robust
responses were obtained upon addition of amiloride, ATP,
or UTP. We present here data which confirm nucleotide-mediated inhibition of Na+ absorption in native human
upper airway tissue from normal individuals and patients
with CF. We demonstrate that both nucleotides, in strictly
paired experiments, induced a transient increase followed by prolonged inhibition of Na+ absorption. Similar fractional (%) inhibition of the amiloride-sensitive Isc in the
range of 40 to 55% was observed for both nucleotides in
non-CF and CF tissues, respectively. However, due to enhanced basal Na+ conductance in CF, the absolute magnitude of nucleotide-mediated inhibition of Na+ absorption
was significantly increased in CF compared with non-CF tissues. Extracellular ATP and UTP were equally effective
in reducing Na+ transport, which suggests that the responses are mediated by luminal P2Y2 receptors (18), coupling to intracellular PLC and G proteins (16, 19). Previous studies on Na+ absorption in renal epithelia showed
attenuation of Na+ transport by an increase in intracellular Ca2+ (21, 23). In another report, ATP-induced inhibition of Na+ absorption did not depend on Ca2+ but was
mediated by PKC (22). We show here that an increase in
intracellular Ca2+ by adding the Ca2+-ATPase inhibitor
CPA results in inhibition of Na+ absorption in the absence
of extracellular nucleotides. Further, nucleotide-mediated
inhibition of Na+ transport is largely reduced in the presence of CPA. The PKC inhibitor BIM had no effect on nucleotide-mediated inhibition of amiloride-sensitive ISC. These
data suggest that a rise of intracellular Ca2+, but not activation of PKC, is involved in inhibition of epithelial Na+
transport in human upper airway tissues, which confirms
previous results obtained from cultured human bronchial
epithelial cells (24). However, in the presence of amiloride,
CPA also inhibited P2Y2-mediated activation of Cl
secretion (unpublished observation from the authors' laboratory). Therefore, the present data do not allow us to discriminate whether Ca2+ acts directly on ENaC or whether
activation of P2Y2-coupled Cl
conductance is required
for inhibition of Na+ absorption. In that respect it is noteworthy that Cl
transport was shown to be essential for
CFTR-mediated inhibition of ENaC (30). Moreover, at this
stage it cannot be excluded that G proteins or direct protein-protein interaction between luminal P2Y2 receptors and
ENaC do contribute to the inhibition of Na+ transport.
According to the present and previously published results, autocrine secretion of nucleotides to the luminal surface of airways inhibits Na+ absorption and activates Cl
secretion. By this mechanism, airway cells could switch
from NaCl absorption to NaCl secretion even in the absence of intact CFTR. Extracellular nucleotides may therefore play an important physiologic role in fine-tuning of the
airway surface liquid lining the superficial respiratory epithelium. Thus, an increase in luminal nucleotide concentration by inhalation of ATP or UTP is expected to counteract enhanced amiloride-sensitive Na+ conductance caused
by CFTR mutations.
Earlier studies have shown that extracellular nucleotides activate an alternative Ca2+-dependent Cl
conductance and increase mucociliary clearance in CF airways, and have proposed the use of ATP and UTP as therapeutic drugs in the treatment of CF lung disease (11, 20). In
the present report we demonstrate that extracellular nucleotides induce significant inhibition of Na+ absorption in
native human non-CF and CF airway tissues. Therefore, topical application of aerosolized ATP or UTP could have
a dual therapeutic effect by counteracting increased Na+
absorption and reduced Cl
secretion in airways from patients with CF.
| |
Footnotes |
|---|
Address correspondence to: Dr. Marcus Mall, Universitäts-Kinderklinik, Albert-Ludwigs-Universität Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany. E-mail: mmall{at}kkl200.ukl.uni-freiburg.de
(Received in original form April 10, 2000 and in revised form July 10, 2000).
Acknowledgments: The authors gratefully thank Professor Laszig, ENT Clinic, University Hospital Freiburg, for his cooperation. They further acknowledge the expert technical assistance by Mrs. S. Hirtz and Mrs. C. Hodler. This study was supported by the Deutsche Forschungs Gemeinschaft grant DFG KU1228/ 1-1 and Zentrum Klinische Forschung 1 (ZKF1, A2), University of Freiburg.
Abbreviations ATP, adenosine 5'-triphosphate; ATPase, adenosine triphosphatase; BIM, bisindolylmaleimide; CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; CPA, cyclopiazonic acid; ENaC, epithelial Na+ channel; Isc, equivalent short-circuit current; PK, protein kinase; Rte, transepithelial resistance; UTP, uridine 5'-triphosphate; Vte, transepithelial voltage.
| |
References |
|---|
|
|
|---|
1.
Boucher, R. C.,
C. U. Cotton,
J. T. Gatzy,
M. R. Knowles, and
J. R. Yankaskas.
1988.
Evidence for reduced Cl
and increased Na+ permeability in
cystic fibrosis human primary cell cultures.
J. Physiol.
405:
77-103
[Medline].
2. Knowles, M. R., J. T. Gatzy, and R. C. Boucher. 1981. Increased biolelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305: 1489-1495 [Medline].
3.
Kunzelmann, K.,
S. Kathöfer, and
R. Greger.
1995.
Na+ and Cl
conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis.
Pflügers Arch.
431:
1-9
[Medline].
4. Mall, M., A. Hipper, R. Greger, and K. Kunzelmann. 1996. Wildtype but not F508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes. FEBS Lett. 381: 47-52 [Medline].
5. Stutts, M. J., C. M. Canessa, J. C. Olsen, M. Hamrick, J. A. Cohn, B. C. Rossier, and R. C. Boucher. 1995. CFTR as a cAMP-dependent regulator of sodium channels. Science 269: 847-850 [Medline].
6. Grubb, B. R., and R. C. Boucher. 1997. Enhanced colonic Na+ absorption in cystic fibrosis mice versus normal mice. Am. J. Physiol. 272: G393-G400 [Medline].
7. Grubb, B. R., R. N. Vick, and R. C. Boucher. 1994. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice. Am. J. Physiol. 266: C1478-C1483 [Medline].
8. Mall, M., M. Bleich, R. Greger, R. Schreiber, and K. Kunzelmann. 1998. The amiloride inhibitable Na+ conductance is reduced by CFTR in normal but not in CF airways. J. Clin. Invest. 102: 15-21 [Abstract/Full Text].
9. Mall, M., M. Bleich, J. Kuehr, M. Brandis, R. Greger, and K. Kunzelmann. 1999. CFTR-mediated inhibition of epithelial Na+ conductance in human colon is defective in cystic fibrosis. Am. J. Physiol. 277: G709-G716 [Medline].
10. Clarke, L. L., and R. C. Boucher. 1992. Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. Am. J. Physiol. 263: C348-C356 [Medline].
11. Knowles, M. R., L. L. Clarke, and R. C. Boucher. 1991. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325: 533-538 [Medline].
12. Kunzelmann, K., H. Pavenstädt, and R. Greger. 1989. Properties and regulation of chloride channels in cystic fibrosis and normal airway epithelial cells. Pflügers Arch. 415: 172-182 [Medline].
13. Mason, S. J., A. M. Paradiso, and R. C. Boucher. 1991. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br. J. Pharmacol. 103: 1649-1656 [Medline].
14.
Zegarra-Moran, O.,
O. Sacco,
L. Romano,
G. A. Rossi, and
L. J. Galietta.
1997.
Cl
currents activated by extracellular nucleotides in human bronchial cells.
J. Membr. Biol.
156:
297-305
[Medline].
15. Brown, H. A., E. R. Lazarowski, R. C. Boucher, and T. K. Harden. 1991. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells. Mol. Pharmacol. 40: 648-655 [Abstract].
16. Nicholas, R. A., W. C. Watt, E. R. Lazarowski, Q. Li, and K. Harden. 1996. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol. Pharmacol. 50: 224-229 [Abstract].
17. Yamaya, M., K. Sekizawa, Y. Kakuta, T. Ohrui, T. Sawai, and H. Sasaki. 1996. P2u-purinoceptor regulation of chloride secretion in cultured human tracheal submucosal glands. Am. J. Physiol. 270: L979-L984 [Medline].
18.
Cressman, V. L.,
E. Lazarowski,
L. Homolya,
R. C. Boucher,
B. H. Koller, and
B. R. Grubb.
1999.
Effect of loss of P2Y(2) receptor gene expression
on nucleotide regulation of murine epithelial Cl(
) transport.
J. Biol.
Chem.
274:
26461-26468
[Abstract/Full Text].
19.
Homolya, L.,
W. C. Watt,
E. R. Lazarowski,
B. H. Koller, and
R. C. Boucher.
1999.
Nucleotide-regulated calcium signaling in lung fibroblasts
and epithelial cells from normal and P2Y(2) receptor (
/
) mice.
J. Biol.
Chem.
274:
26454-26460
[Abstract/Full Text].
20. Bennett, W. D., K. N. Olivier, K. L. Zeman, K. W. Hohneker, R. C. Boucher, and M. R. Knowles. 1996. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am. J. Respir. Crit. Care Med. 153: 1796-1801 [Abstract].
21. Ishikawa, T., Y. Marunaka, and D. Rotin. 1998. Electrophysiological characterization of the rat epithelial Na+ channel (rENaC) expressed in MDCK cells: effects of Na+ and Ca2+. J. Gen. Physiol. 111: 825-846 [Abstract/Full Text].
22. Koster, H. P., A. Hartog, C. H. van Os, and R. J. Bindels. 1996. Inhibition of Na+ and Ca2+ reabsorption by P2u purinoceptors requires PKC but not Ca2+ signaling. Am. J. Physiol. 270: F53-F60 [Medline].
23. Silver, R. B., G. Frindt, E. E. Windhager, and L. G. Palmer. 1993. Feedback regulation of Na channels in rat CCT: I. Effects of inhibition of Na pump. Am. J. Physiol. 264: F557-F564 [Medline].
24. Devor, D. C., and J. M. Pilewski. 1999. UTP inhibits Na+ absorption in wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am. J. Physiol. 276: C827-C837 [Medline].
25.
Inglis, S. K.,
A. Collett,
H. L. McAlroy,
S. M. Wilson, and
R. E. Olver.
1999.
Effect of luminal nucleotides on Cl
secretion and Na+ absorption in distal bronchi.
Pflügers Arch.
438:
621-627
[Medline].
26.
Iwase, N.,
T. Sasaki,
S. Shimura,
M. Yamamoto,
S. Suzuki, and
K. Shirato.
1997.
ATP-induced Cl
secretion with suppressed Na+ absorption in rabbit tracheal epithelium.
Respir. Physiol.
107:
173-180
[Medline].
27. Ramminger, S. J., A. Collett, D. L. Baines, H. Murphie, H. L. McAlroy, R. E. Olver, S. K. Inglis, and S. M. Wilson. 1999. P2Y2 receptor-mediated inhibition of ion transport in distal lung epithelial cells. Br. J. Pharmacol. 128: 293-300 [Abstract/Full Text].
28. Boucher, R. C., M. J. Stutts, M. R. Knowles, L. Cantley, and J. T. Gatzy. 1986. Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78: 1245-1252 [Medline].
29. Lazarowski, E. R., W. C. Watt, M. J. Stutts, R. C. Boucher, and T. K. Harden. 1995. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116: 1619-1627 [Medline].
30.
Briel, M., R. Greger, and K. Kunzelmann. 1998. Cl
transport by CFTR
contributes to the inhibition of epithelial Na+ channels in Xenopus
ooyctes coexpressing CFTR and ENaC. J. Physiol. (Lond.) 508.3:825-836.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |